Enteromix, Russia’s cancer vaccine achieves 100% efficacy in clinical trials
In what could be a miracle improving and saving thousands of lives across the globe, Russia’s mRNA-based vaccine…
Rivaroxaban or Combo Therapy: A Winner for All Ages? – Medscape
Rivaroxaban or Combo Therapy: A Winner for All Ages? Medscape Rivaroxaban Monotherapy Benefits Those with Atrial Fibrillation, Stable Coronary…
FDA Approves Tonix’s Tonmya for Fibromyalgia, First New Drug in 15 Years
Tonix Pharmaceuticals (Nasdaq: TNXP) has received FDA approval for Tonmya™,…
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjögren’s disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are the first ever global phase III…
Ultra-processed foods make up a big portion of Americans’ diet, CDC finds
Most Americans get more than half their calories from ultra-processed foods, those super-tasty, energy-dense foods typically full of…
Is your Vitamin, magnesium supplement really the magic pill you think it is? Experts reveal truths behind India’s new health obsession | Eye News
The Arora family in a plush condominium of Noida believes an apple is simply not enough to keep…
First New PTSD Drug in Two Decades On the Horizon?
The Psychopharmacologic Drugs Advisory Committee of the FDA is set to meet on July 18 to consider a…
Synthetic DNA Nanoparticles for Gene Therapy
Newswise — CLEVELAND—Case Western Reserve University chemist Divita Mathur was awarded a National Science Foundation (NSF) Faculty Early…
AAV gene therapy for autosomal recessive deafness 9: a single-arm trial
Chang, Q. et al. Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in…
FDA Approves First Treatment for MAS in Still Disease
The FDA has approved the interferon gamma-blocking antibody emapalumab-lzsg (Gamifant) for the treatment of macrophage activation syndrome (MAS)…